Search results for "PRF"

showing 10 items of 13 documents

Peripheral ossifying fibroma:a 20-year retrospective study with focus on clinical and morphological features

2022

Peripheral Ossifying Fibroma (POF) is a reactive hyperplastic lesion that exclusively occurs in the gingiva and is characterized by the deposition of dystrophic calcification, cementum-like tissue, and immature and mature bone within the connective tissue. The objective of the present study was to perform a retrospective analysis of clinicopathologic features of POF. Clinical and histopathological data were obtained from biopsy records and histopathological reports from a Brazilian reference service in Oral Pathology (1999 - 2020). Morphological analysis was performed to evaluate features related to the mesenchymal component, inflammatory infiltrate, ulceration, and mineralized tissue. A to…

Gingival NeoplasmsHyperplasiaGingival-prfsocket preservationOtorhinolaryngologyFibroma OssifyingHumansFemaleSurgerybone healingGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective Studies
researchProduct

NEW GUIDED BONE REGENERATION PROCEDURE USING LEUKOCYTE AND PLATELET RICH FIBRIN (L PRF) IN ORAL SURGERY

2021

Non-transfusional hemocomponents are autogenous products used in several surgical fields obtained by the centrifugation of a blood sample from a patient and able to promote hard and soft tissue regeneration, local haemostasis, and the acceleration of wound healing. The aim of this PhD thesis was the validation of an innovative protocol for the Guided Bone Regeneration (GBR) technique using second-generation autologous platelet concentrates, Leukocytes and Platelet-rich Fibrin (L-PRF), in post-extraction sockets of patients in need of dental avulsions and successive implant prosthetic rehabilitation, evaluating its ability to prevent alveolar bone resorption and promote bone regeneration. Th…

Guided Bone Regenerationtooth extractionmetronidazolenanocompositeSettore MED/28 - Malattie OdontostomatologicheSettore CHIM/09 - Farmaceutico Tecnologico Applicativohyaluronic acid.platelet-rich fibrinL-PRFcurcuminnon-transfusional hemocomponentnanostructured lipid carrierhydrophilic sponge
researchProduct

Healing evaluation by means of Optical Coherence Tomography of an extraction socket with L-PRF application in a patient at ONJ risk: a case report

2016

healing oct l-prf onj extraction socketSettore MED/28 - Malattie Odontostomatologiche
researchProduct

Ozone insufflation and l-prf application in an idiopathic and recurrent case of osteonecrosis of the maxilla

2019

Ozone insufflation l-prf osteonecrosis
researchProduct

Surgical treatment of medication-related osteonecrosis of the jaws with addiction of L-PRF: preliminary results

2018

Surgical treatment medication-related osteonecrosis of the jaws L-PRF
researchProduct

Cellular cytotoxicity against the human hepatoma cell line PLC/PRF/5 in patients with hepatitis B virus-induced chronic active hepatitis (CAH) and no…

2008

Hepatitis B virusHepatitisHepatologybusiness.industryChronic Activemedicine.disease_causemedicine.diseaseVirologyPlc prf 5Hepatoma cell linemedicineIn patientCell-mediated cytotoxicitybusinessLiver
researchProduct

Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis

2006

Familial haemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous disorder characterised by constitutive defects in cellular cytotoxicity resulting in fever, hepatosplenomegaly and cytopenia, and the outcome is fatal unless treated by chemoimmunotherapy followed by haematopoietic stem‐cell transplantation. Since 1999, mutations in the perforin gene giving rise to this disease have been identified; however, these account only for 40% of cases. Lack of a genetic marker hampers the diagnosis, suitability for transplantation, selection of familial donors, identification of carriers, genetic counselling and prenatal diagnosis. Mutations in the Munc13–4 gene have recently been des…

EXPRESSIONMalePRF1AdolescentFHLBlotting WesternDNA Mutational AnalysisHepatosplenomegalyDONORSPrenatal diagnosisBiologymedicine.disease_causeLymphohistiocytosis HemophagocyticGeneticsmedicinePERFORIN GENE-MUTATIONSHumansUNC13DChildGenetics (clinical)Family HealthSPECTRUMHemophagocytic lymphohistiocytosisMutationCytopeniaMicroscopy ConfocalIDENTIFICATIONGenetic heterogeneityInfant NewbornCYTOTOXIC T-LYMPHOCYTESInfantMembrane Proteinsmedicine.diseaseBONE-MARROW-TRANSPLANTATIONTransplantationMicroscopy ElectronChild PreschoolMutationImmunologyFemalemedicine.symptomLetter to JMGT-Lymphocytes CytotoxicJournal of Medical Genetics
researchProduct

Development of a Multifunctional Bioerodible Nanocomposite Containing Metronidazole and Curcumin to Apply on L-PRF Clot to Promote Tissue Regeneratio…

2020

Teeth extractions are often followed by alveolar bone reabsorption, although an adequate level of bone is required for reliable rehabilitations by dental implants. Leukocyte and platelet-rich fibrin (L-PRF) has been widely applied in regenerative procedures and with antibiotic and antioxidant agents could play an essential role in hard and soft tissue healing. In this work, a nanocomposite (Sponge-C-MTR) consisting of a hyaluronate-based sponge loaded with metronidazole (MTR) and nanostructured lipid carriers containing curcumin (CUR-NLC) was designed to be wrapped in the L-PRF&trade

Sonicationnanostructured lipid carriersMedicine (miscellaneous)02 engineering and technologynanostructured lipid carrier030226 pharmacology & pharmacyhydrophilic spongeGeneral Biochemistry Genetics and Molecular BiologyArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemetronidazolebone regenerationSettore MED/28 - Malattie OdontostomatologicheHyaluronic acidhyaluronic acidZeta potentialcurcuminBone regenerationlcsh:QH301-705.5Dental alveolustooth extractionNanocompositenanocompositeChemistryRegeneration (biology)hyaluronic acid.L-PRFBuccal administration021001 nanoscience & nanotechnologylcsh:Biology (General)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo0210 nano-technologyBiomedical engineeringBiomedicines
researchProduct

Leucocyte- and Platelet-Rich Fibrin Block: Its Use for the Treatment of a Large Cyst with Implant-Based Rehabilitation

2021

The management of critical-size bone defects is still demanding. Recently, autologous platelet concentrates in combination with bone substitute have been applied and reported in a few studies. Our aim is to report the healing of a critical-size alveolar bone defect treated with a new bone regeneration technique by means of L-PRF and L-PRF blocks. A 45-year-old woman presented a large cystic lesion; the extraction of three teeth, a cyst removal procedure, and bone regeneration procedures with L-PRF and L-PRF blocks were planned. The L-PRF block was prepared by mixing a bone substitute with a piece of L-PRF membrane and liquid fibrinogen. Additionally, after bone healing an implant-based reha…

medicine.medical_specialtyMedicine (General)odontogenic cystplatelet-rich fibrin02 engineering and technologyBone healingLarge cyst03 medical and health sciences0302 clinical medicineR5-920Odontogenic cystbone regenerationPRF blockmedicinecase reportCystBone regenerationDental alveolusbusiness.industry030206 dentistryGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseasePlatelet-rich fibrindigestive system diseasesSurgeryImplant0210 nano-technologybusinessPRFMedicina
researchProduct

Activation of Human Osteoblasts via Different Bovine Bone Substitute Materials With and Without Injectable Platelet Rich Fibrin in vitro

2021

IntroductionThe aim of the in vitro study was to compare the effect of four bovine bone substitute materials (XBSM) with and without injectable platelet-reach fibrin for viability and metabolic activity of human osteoblasts (HOB) as well as expression of alkaline phosphatase (ALP), bone morphogenetic protein 2 (BMP-2), and osteonectin (OCN).Materials and MethodsCerabone® (CB), Bio-Oss® (BO), Creos Xenogain® (CX) and MinerOss® X (MO) ± i-PRF were incubated with HOB. At day 3, 7, and 10, cell viability and metabolic activity as well as expression of ALP, OCN, and BMP-2, was examined.ResultsFor non-i-PRF groups, the highest values concerning viability were seen for CB at all time points. Pre-t…

Histologyplatelet rich fibrin (PRF)proliferationlcsh:BiotechnologyBiomedical EngineeringBioengineering02 engineering and technologyBone morphogenetic protein 2vitalityFibrinAndrology03 medical and health sciences0302 clinical medicinelcsh:TP248.13-248.65medicineViability assaybovine boneOriginal ResearchbiologyChemistryBioengineering and Biotechnologyin vitroOsteoblastbone substitute030206 dentistry021001 nanoscience & nanotechnologydigestive system diseasesPlatelet-rich fibrinIn vitroPCRmedicine.anatomical_structureosteoblastbiology.proteinAlkaline phosphataseOsteonectin0210 nano-technologyBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct